Keenova Therapeutics plc

EDGAR

Market value is not computed: no recent price is available.

248 filing records in this dataset, filed from 2013-08-12 to 2026-11-10. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
12 transactions, 2,509,842 shares
Sum of shares × price per share: 226,615,177.5
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-11-10 GOLDENTREE ASSET MANAGEMENT LP P 120,652 91.00
  • 2026-11-09 GOLDENTREE ASSET MANAGEMENT LP P 30,000 89.25
  • 2026-11-06 GOLDENTREE ASSET MANAGEMENT LP P 150,000 89.25
  • 2026-11-05 GOLDENTREE ASSET MANAGEMENT LP P 145,716 89.25
  • 2026-10-14 GOLDENTREE ASSET MANAGEMENT LP P 137,000 90.00

5% holders (Schedule 13D and 13G)

  • GoldenTree Asset Management LP 22.3% SCHEDULE 13D/A 11/06/2026
  • GoldenTree Asset Management LLC 22.3% SCHEDULE 13D/A 11/06/2026
  • Steven A. Tananbaum 22.4% SCHEDULE 13D/A 11/06/2026

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Short annual reporting periods

These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.

Corrected figures
MeasurePeriodValue
Capital expenditure2023-11-15 – 2023-12-292200000 USD Source Dispute
Cost of revenue2023-11-15 – 2023-12-2984900000 USD Source Dispute
Gross profit2023-11-15 – 2023-12-2954900000 USD Source Dispute
Net income2023-11-15 – 2023-12-29-38200000 USD Source Dispute
Operating cash flow2023-11-15 – 2023-12-2973400000 USD Source Dispute
Operating income2023-11-15 – 2023-12-29-16900000 USD Source Dispute
Research and development2023-11-15 – 2023-12-2911800000 USD Source Dispute
Selling, general and administrative2023-11-15 – 2023-12-2956000000 USD Source Dispute
Capital expenditure2022-06-17 – 2022-12-3028800000 USD Source Dispute
Cost of revenue2022-06-17 – 2022-12-30991000000 USD Source Dispute
Gross profit2022-06-17 – 2022-12-3048700000 USD Source Dispute
Net income2022-06-17 – 2022-12-30-598100000 USD Source Dispute
Operating cash flow2022-06-17 – 2022-12-3047100000 USD Source Dispute
Operating income2022-06-17 – 2022-12-30-316700000 USD Source Dispute
Research and development2022-06-17 – 2022-12-3064200000 USD Source Dispute
Selling, general and administrative2022-06-17 – 2022-12-30268900000 USD Source Dispute
Cash and cash equivalents
1.09 billion USD Source
Exact value

1085600000 USD

Long-term debt including current maturities
3.58 billion USD Derived
Exact inputs and evidence

3583600000 USD

Calculated as noncurrent long-term debt plus its current portion.

  • Current portion of long-term debt: 44100000 USD Source
  • Long-term debt: 3539500000 USD Source
Shares outstanding
19.7 million shares Source
Exact value

19736759 shares

Reported share-count change

0.21% · 40.4 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 19696335 shares · 2024-06-28· Source
  • 19736759 shares · 2025-06-27· Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-10.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 8 of 11 periods available· newest 2025-12-31
  • Net income: 8 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 8 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2025-12-31
  • Total assets: 8 of 11 periods available· newest 2025-12-31
  • Total liabilities: 8 of 11 periods available· newest 2025-12-31
  • Current assets: 8 of 11 periods available· newest 2025-12-31
  • Current liabilities: 8 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 7 of 11 periods available· newest 2024-12-27

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    -202.4%

    Prior period

    USD 477.9 million

    –

    Current period

    −USD 489.5 million

    –

    Exact inputs and evidence

    -489500000 − 477900000 = -967400000 USD

    477900000 USD · 2023-12-30 – 2024-12-27

    Inspect prior input Prior source

    -489500000 USD · 2024-12-28 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 173 million

    Prior period

    −USD 48 million

    –

    Current period

    USD 125 million

    –

    Exact inputs and evidence

    125000000 − -48000000 = 173000000 USD

    -48000000 USD · 2023-12-30 – 2024-12-27

    Inspect prior input Prior source

    125000000 USD · 2024-12-28 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -8%

    Prior period

    USD 54.8 million

    –

    Current period

    USD 50.4 million

    –

    Exact inputs and evidence

    50400000 − 54800000 = -4400000 USD

    54800000 USD · 2023-12-30 – 2024-12-27

    Inspect prior input Prior source

    50400000 USD · 2024-12-28 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2015-09-26 – 2016-09-30
USD 643.7 million
Exact value

Exact value: 643700000 USD

2015-09-26 – 2016-09-30: 643700000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.18 billion
Exact value

Exact value: 1184600000 USD

2015-09-26 – 2016-09-30: 1184600000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 182.9 million
Exact value

Exact value: 182900000 USD

2015-09-26 – 2016-09-30: 182900000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1 billion
Calculation and evidence

1184600000 − 182900000 USD

Exact free cash flow: 1001700000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2016-12-31 – 2017-12-29
USD 2.13 billion
Exact value

Exact value: 2134400000 USD

2016-12-31 – 2017-12-29: 2134400000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 727.3 million
Exact value

Exact value: 727300000 USD

2016-12-31 – 2017-12-29: 727300000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 186.1 million
Exact value

Exact value: 186100000 USD

2016-12-31 – 2017-12-29: 186100000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 541.2 million
Calculation and evidence

727300000 − 186100000 USD

Exact free cash flow: 541200000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2017-12-30 – 2018-12-28
−USD 3.61 billion
Exact value

Exact value: -3607000000 USD

2017-12-30 – 2018-12-28: -3607000000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 665.5 million
Exact value

Exact value: 665500000 USD

2017-12-30 – 2018-12-28: 665500000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 127 million
Exact value

Exact value: 127000000 USD

2017-12-30 – 2018-12-28: 127000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 538.5 million
Calculation and evidence

665500000 − 127000000 USD

Exact free cash flow: 538500000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2018-12-29 – 2019-12-27
−USD 996.5 million
Exact value

Exact value: -996500000 USD

2018-12-29 – 2019-12-27: -996500000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 742.9 million
Exact value

Exact value: 742900000 USD

2018-12-29 – 2019-12-27: 742900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 133 million
Exact value

Exact value: 133000000 USD

2018-12-29 – 2019-12-27: 133000000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 609.9 million
Calculation and evidence

742900000 − 133000000 USD

Exact free cash flow: 609900000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2019-12-28 – 2020-12-25
−USD 944.6 million
Exact value

Exact value: -944600000 USD

2019-12-28 – 2020-12-25: -944600000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 498.9 million
Exact value

Exact value: 498900000 USD

2019-12-28 – 2020-12-25: 498900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 47.7 million
Exact value

Exact value: 47700000 USD

2019-12-28 – 2020-12-25: 47700000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 451.2 million
Calculation and evidence

498900000 − 47700000 USD

Exact free cash flow: 451200000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2020-12-26 – 2021-12-31
−USD 717.4 million
Exact value

Exact value: -717400000 USD

2020-12-26 – 2021-12-31: -717400000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 455.4 million
Exact value

Exact value: 455400000 USD

2020-12-26 – 2021-12-31: 455400000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 55.3 million
Exact value

Exact value: 55300000 USD

2020-12-26 – 2021-12-31: 55300000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 400.1 million
Calculation and evidence

455400000 − 55300000 USD

Exact free cash flow: 400100000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2023-12-30 – 2024-12-27
USD 477.9 million
Exact value

Exact value: 477900000 USD

2023-12-30 – 2024-12-27: 477900000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 48 million
Exact value

Exact value: -48000000 USD

2023-12-30 – 2024-12-27: -48000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 54.8 million
Exact value

Exact value: 54800000 USD

2023-12-30 – 2024-12-27: 54800000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 102.8 million
Calculation and evidence

-48000000 − 54800000 USD

Exact free cash flow: -102800000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2024-12-28 – 2025-12-31
−USD 489.5 million
Exact value

Exact value: -489500000 USD

2024-12-28 – 2025-12-31: -489500000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 125 million
Exact value

Exact value: 125000000 USD

2024-12-28 – 2025-12-31: 125000000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 50.4 million
Exact value

Exact value: 50400000 USD

2024-12-28 – 2025-12-31: 50400000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 74.6 million
Calculation and evidence

125000000 − 50400000 USD

Exact free cash flow: 74600000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

248 filings · 4,283 latest values · 4,283 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001567892, 1567892, MNK, MNKKQ(1), MNKTQ (1), edgar:1567892

Also known as Keenova Therapeutics plc, Mallinckrodt plc